|
|
| | | | | | Dear colleagues,
| | | | | | | | We are pleased to inform you that the abstract submission for the upcoming 14th International Symposium on Hodgkin Lymphoma (ISHL14) has been extended until June 15, 2026 (11:59 pm, CEST) | | | | | |
|
| | | | | | Abstract Submission | | | | | | | | Please submit your abstract to actively shape the program of ISHL14 and share your work at the premier meeting for Hodgkin Lymphoma. Notification of abstract acceptance will be sent to the presenting author by the beginning of August 2024. All accepted abstracts will be published in a supplement of “HemaSphere”, the official journal of the European Hematology Association (EHA). Awards will be granted to the best abstracts during the opening ceremony of the congress.
| | | | | | | | | | | | | |
|
 |
| | | | | | Registration | | | | | | | | To ensure a quick and correct processing of your registration information, please use the online registration.
| | | | | | | | | | | | | |
|
| | | | | | ISHL14 will take place from October 03 to 05, 2026 in Cologne, Germany. Please visit our website for further information.
| | | | | |
|
| | All the best,
| | | | | | | | Peter Borchmann, MD,
Symposium Chairman | |
Paul J. Bröckelmann, MD,
Symposium Co-Chair | |
Dennis Eichenauer, MD,
Symposium Co-Chair | |
Justin Ferdinandus, MD,
Symposium Co-Chair | |
| | | | |
|
|
|